PERIPHERAL T CELLS LYMPHOMA (PTCL)
Clinical trials for PERIPHERAL T CELLS LYMPHOMA (PTCL) explained in plain language.
Never miss a new study
Get alerted when new PERIPHERAL T CELLS LYMPHOMA (PTCL) trials appear
Sign up with your email to follow new studies for PERIPHERAL T CELLS LYMPHOMA (PTCL), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Promising new combo offers hope for patients with aggressive lymphoma
Disease control Recruiting nowThis study tests a new mix of three drugs—zeprumetostat, azacitidine, and mitoxantrone hydrochloride liposome—in adults whose peripheral T-cell lymphoma has come back or not responded to earlier treatments. About 26 people will receive up to 6 cycles of the combination, then up t…
Matched conditions: PERIPHERAL T CELLS LYMPHOMA (PTCL)
Phase: PHASE2 • Sponsor: The First Affiliated Hospital of Soochow University • Aim: Disease control
Last updated May 18, 2026 12:00 UTC
-
New hope for rare blood cancer: platform trial seeks better treatments
Knowledge-focused Recruiting nowThis study is testing new drugs or drug combinations for people with peripheral T-cell lymphoma that has come back or stopped responding to treatment. The main goal is to gather early information on safety and effectiveness to help design larger, more focused future studies. Abou…
Matched conditions: PERIPHERAL T CELLS LYMPHOMA (PTCL)
Phase: PHASE1, PHASE2 • Sponsor: The Lymphoma Academic Research Organisation • Aim: Knowledge-focused
Last updated May 19, 2026 11:49 UTC